Takahiko Tanigawa

发表

Evaluation of interethnic differences in repinotan pharmacokinetics by using population approach.

S. Higuchi, R. Heinig, Takahiko Tanigawa, 2006, Drug metabolism and pharmacokinetics.

First-in-Human Phase I Study of Aprutumab Ixadotin, a Fibroblast Growth Factor Receptor 2 Antibody–Drug Conjugate (BAY 1187982) in Patients with Advanced Cancer

Sung-Bae Kim, J. Berlin, F. Meric-Bernstam, 2019, Targeted Oncology.

Population Pharmacokinetics of Ramatroban in Healthy Volunteers and Patients with Bronchial Asthma/Perennial Allergic Rhinitis

E. Yukawa, S. Higuchi, Takahiko Tanigawa, 1997 .

Effects of grapefruit juice on the pharmacokinetics of the calcium channel blockers nifedipine and nisoldipine

J. Azuma, I. Yamamoto, K. Yoshikawa, 1998 .

A comprehensive review of the pharmacokinetics of approved therapeutic monoclonal antibodies in Japan: Are Japanese phase I studies still needed?

K. Yoneyama, S. Iida, H. Yoshitsugu, 2014, Journal of clinical pharmacology.

A case of basal cell carcinoma of the nipple and areola with intraductal spread

Yasuhiro Ito, N. Kikkawa, Takeshi Kato, 2001, Breast cancer.

A CASE OF DIVERTICULITIS OF THE APPENDIX DUE TO ABERRATION OF FISH BONES TO THE DIVERTICULA

Takeshi Kato, M. Goto, Taro Hayashi, 2000 .

Phase I clinical and pharmacokinetic study of sorafenib in combination with carboplatin and paclitaxel in patients with advanced non–small cell lung cancer

M. Fukuoka, A. Kawada, T. Satoh, 2009, Investigational New Drugs.

A Case of Hilar Bile Duct Carcinoma Died of Pleuritis Carcinomatosa Induced by Percutaneus Bile Duct Drainage Despite Absolute Curative Resection

M. Monden, K. Dono, H. Nagano, 1998 .

Efficacy, safety and pharmacokinetics of tedizolid versus linezolid in patients with skin and soft tissue infections in Japan - Results of a randomised, multicentre phase 3 study.

S. Kohno, Y. Tanimura, H. Mikamo, 2018, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Phase I trial of sorafenib in combination with interferon-alpha in Japanese patients with unresectable or metastatic renal cell carcinoma

Y. Hamamoto, H. Fujii, K. Fukino, 2009, Investigational new drugs.

Model-based dose selection for phase III rivaroxaban study in Japanese patients with non-valvular atrial fibrillation.

J. Paolini, W. Mueck, M. Kaneko, 2013, Drug metabolism and pharmacokinetics.

Computational investigation of potential dosing schedules for a switch of medication from warfarin to rivaroxaban—an oral, direct Factor Xa inhibitor

Rolf Burghaus, Christoph Niederalt, Jörg Lippert, 2014, Front. Physiol..

Confirmation of model-based dose selection for a Japanese phase III study of rivaroxaban in non-valvular atrial fibrillation patients.

W. Mueck, M. Kaneko, Masahiro Tajiri, 2013, Drug metabolism and pharmacokinetics.

A CASE OF BASALOID-SQUAMOUS CELL CARCINOMA OF THE ESOPHAGUS RESECTED AFTER CHEMOTHERAPY

H. Ikegawa, Shinji Yamamoto, E. Kurokawa, 1998 .

[Laparoscopy-Assisted Surgery for Descending Colon Cancer in a Patient with Persistent Descending Mesocolon-A Case Report].

I. Higuchi, J. Gofuku, Y. Mori, 2018, Gan to kagaku ryoho. Cancer & chemotherapy.

A new regimen for S-1 therapy aiming at adverse reaction mitigation and prolonged medication by introducing a 1-week drug-free interval after each 2-week dosing session: efficacy and feasibility in clinical practice

N. Kikkawa, S. Iijima, Y. Naoi, 2003, Gastric Cancer.

[Usefulness of TS-1 and lentinan combination immunochemotherapy in advanced or recurrent gastric cancer--pilot study aiming at a randomized trial].

N. Matsuura, N. Kikkawa, M. Tsujie, 2003, Gan to kagaku ryoho. Cancer & chemotherapy.

Comment on model-based meta-analysis to evaluate optimal doses of direct oral factor Xa inhibitors in atrial fibrillation patients.

S. Berkowitz, R. Burghaus, J. Weitz, 2018, Blood advances.